Group One Trading, L.P. Ngm Biopharmaceuticals Inc Transaction History

Group One Trading, L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$0.6 - $1.31 $360 - $786	600 Added 132.74%	1,052 $0
Q3 2023 Nov 09, 2023	BUY	$1.05 - $3.37 $474 - $1,523	452 New	452 $0
Q3 2022 Nov 09, 2022	BUY	$12.59 - $17.67 $54,011 - $75,804	4,290 New	4,290 $56,000
Q2 2021 Aug 10, 2021	SELL	$15.06 - $30.03 $1,506 - $3,003	-100 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$15.59 - $19.97 $1,559 - $1,997	100 New	100 $2,000

2.6M

300

Ticker NGM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,365,904
Description
NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an engineered analog of human hormone fibroblast growth factor 19, which is in Phase IIb clinical trial...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.